Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the clinical efficacy and safety of ISV-305 (Dexamethasone in DuraSite® 2) compared to Vehicle in the treatment of subjects with active, symptomatic Blepharitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01543490
Study type Interventional
Source Sun Pharmaceutical Industries Limited
Contact
Status Completed
Phase Phase 3
Start date March 30, 2018
Completion date February 4, 2020